The Role of nab-Paclitaxel Plus Gemcitabine Therapy for Recurrent Pancreatic Cancer Refractory to Gemcitabine and S-1

被引：0
|
作者：
Kagawa, S. [1 ]
Yoshitomi, H. [1 ]
Shimizu, H. [1 ]
Ohtsuka, M. [1 ]
Kato, A. [1 ]
Furukawa, K. [1 ]
Takayashiki, T. [1 ]
Takano, S. [1 ]
Kuboki, S. [1 ]
Suzuki, D. [1 ]
Sakai, N. [1 ]
Miyazaki, M. [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan
来源：
PANCREAS | 2015年 / 44卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1385 / 1385
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma
    Zhu, Zhou
    Tang, Hui
    Ying, Jinrong
    Cheng, Yuejuan
    Wang, Xiang
    Wang, Yingyi
    Bai, Chunmei
    CANCER BIOLOGY & MEDICINE, 2023, 20 (10) : 765 - 778
  • [42] Erratum: Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
    E Gabriela Chiorean
    Daniel D Von Hoff
    Josep Tabernero
    Robert El-Maraghi
    Wen Wee Ma
    Michele Reni
    Marion Harris
    Robert Whorf
    Helen Liu
    Jack Shiansong Li
    Victoria Manax
    Alfredo Romano
    Brian Lu
    David Goldstein
    British Journal of Cancer, 2016, 115 : e13 - e13
  • [43] Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment
    Angelica Petrillo
    Annalisa Pappalardo
    Luca Pompella
    Giuseppe Tirino
    Filomena Calabrese
    Maria Maddalena Laterza
    Marianna Caterino
    Anna Ventriglia
    Michele Orditura
    Giovanni Conzo
    Carlo Molino
    Fortunato Ciardiello
    Maria Biglietto
    Ferdinando De Vita
    Medical Oncology, 2019, 36
  • [44] Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment
    Petrillo, Angelica
    Pappalardo, Annalisa
    Pompella, Luca
    Tirino, Giuseppe
    Calabrese, Filomena
    Laterza, Maria Maddalena
    Caterino, Marianna
    Ventriglia, Anna
    Orditura, Michele
    Conzo, Giovanni
    Molino, Carlo
    Ciardiello, Fortunato
    Biglietto, Maria
    De Vita, Ferdinando
    MEDICAL ONCOLOGY, 2019, 36 (10)
  • [45] Health-Related Quality of Life for Gemcitabine and Nab-paclitaxel Plus Radiation Therapy Versus Gemcitabine and S-1 Plus Radiation Therapy in Patients with Metastatic Pancreatic Cancer: A Propensity Score Matched Analysis
    Zhu, X.
    Li, F.
    Shi, D.
    Ju, X.
    Cao, Y.
    Shen, Y.
    Cao, F.
    Qing, S.
    Fang, F.
    Jia, Z.
    Zhang, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E82 - E82
  • [46] The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma
    Palacio, Sofia
    Hosein, Peter J.
    Reis, Isildinha
    Akunyili, Ikechukwu I.
    Ernani, Vinicius
    Pollack, Terri
    Macintyre, Jessica
    Restrepo, Maria H.
    Merchan, Jaime R.
    Lima, Caio M. Rocha
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (01) : 135 - 139
  • [47] Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Resected Pancreatic Cancer in a Phase III Trial (APACT)
    Tempero, Margaret
    Cardin, Dana
    Biankin, Andrew V.
    Goldstein, David
    Moore, Malcolm
    O'Reilly, Eileen
    Philip, Philip
    Riess, Hanno
    Macarulla, Teresa
    Yung, Lotus
    Li, Mingyu
    Lu, Brian
    GASTROENTEROLOGY, 2015, 148 (04) : S944 - S944
  • [48] ECONOMIC EVALUATION OF NAB-PACLITAXEL PLUS GEMCITABINE VERSUS GEMCITABINE ALONE FOR THE MANAGEMENT OF METASTATIC PANCREATIC CANCER IN GREECE
    Fragoulakis, V
    Papakostas, P.
    Pentheroudakis, G.
    Dervenis, C.
    Maniadakis, N.
    VALUE IN HEALTH, 2014, 17 (07) : A632 - A632
  • [49] Phase I Study of Nab-Paclitaxel plus Gemcitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
    Okada, Ken-Ichi
    Hirono, Seiko
    Kawai, Manabu
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Ueno, Masaki
    Hayami, Shinya
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2017, 37 (02) : 853 - 858
  • [50] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
12345